AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11221017 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan/paclitaxel/carboplatin
Number of subjects: 0
Study 11221017 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan/docetaxel
Number of subjects: 0
Study 11221017 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin or irinotecan in combination with docetaxel
Number of subjects: 0
Study 11221017 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan and gemcitabine
Number of subjects: 0
Study 9627292 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin plus HRT
Number of subjects: 42
Study 9627292 — intervention group
Group type: COMPARATOR
Intervention: Goserelin alone
Number of subjects: 42
Study 9627292 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT1 and HRT2 groups
Number of subjects: 42
Study 9627292 — intervention group
Group type: COMPARATOR
Intervention: HRT0 group
Number of subjects: 42
Study 8149803 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with pre-peritoneal implantation of a prosthetic mesh
Number of subjects: 250
Study 3382587 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 5 mg twice daily for 7 days
Number of subjects: 6
Study 30659559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 148
Study 30659559 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 148
Study 27697703 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge
Number of subjects: 25
Study 24915259 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed casein formula
Number of subjects: 2159
Study 24915259 — intervention group
Group type: COMPARATOR
Intervention: Conventional cows' milk‐based formula
Number of subjects: 2159
Study 21846665 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent education sessions and coaching sessions
Number of subjects: 0
Study 20840231 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received a program aimed at improving representation and transformation of visuospatial information.
Number of subjects: 116
Study 20840231 — intervention group
Group type: COMPARATOR
Intervention: Control group received a substitute program.
Number of subjects: 116
Study 17526436 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS
Number of subjects: 102
Study 17526436 — intervention group
Group type: COMPARATOR
Intervention: ICBG
Number of subjects: 102
Study 15891633 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency tympanostomy (Group B)
Number of subjects: 96
Study 15891633 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency tympanostomy with topical mitomycin C application (Group C)
Number of subjects: 96
Study 15891633 — intervention group
Group type: COMPARATOR
Intervention: Cold knife myringotomy (Group A)
Number of subjects: 96
Study 11982640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a single-strain Leishmania amazonensis killed promastigote vaccine plus a half dose of meglumine antimoniate.
Number of subjects: 102
Study 11982640 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus half dose of meglumine antimoniate.
Number of subjects: 102
Study 10553612 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management services
Number of subjects: 8248
Study 10553612 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonparticipants)
Number of subjects: 8248
Study 8684633 — intervention group
Group type: EXPERIMENTAL
Intervention: NLA in N2O-O2
Number of subjects: 64
Study 8684633 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus fentanyl in air-O2
Number of subjects: 64
Study 8684633 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 64
Study 2195136 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) + leucovorin
Number of subjects: 0
Study 2195136 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5FU) alone
Number of subjects: 0
Study 7461567 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone-citrate combination (Harolan)
Number of subjects: 21
Study 31470443 — intervention group
Group type: EXPERIMENTAL
Intervention: Two horizontally aligned pins (H)
Number of subjects: 18
Study 31470443 — intervention group
Group type: EXPERIMENTAL
Intervention: Two vertically aligned pins (V)
Number of subjects: 18
Study 31470443 — intervention group
Group type: EXPERIMENTAL
Intervention: Two horizontally aligned pins with a tension band wire (H-TB)
Number of subjects: 18
Study 31470443 — intervention group
Group type: EXPERIMENTAL
Intervention: Two vertically aligned pins with a tension band wire (V-TB)
Number of subjects: 18
Study 31470443 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tension band)
Number of subjects: 18
Study 31470443 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension band (TB) constructs
Number of subjects: 18
Study 30611202 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngoscope-guided insertion
Number of subjects: 100
Study 30611202 — intervention group
Group type: COMPARATOR
Intervention: Blind insertion
Number of subjects: 100
Study 30611202 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 26847527 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic intervention including daily training program with movements to increase chest flexibility, breathing exercises, and relaxation sessions.
Number of subjects: 41
Study 26847527 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic intervention
Number of subjects: 41
Study 25756412 — intervention group
Group type: COMPARATOR
Intervention: IV propofol (n = 74)
Number of subjects: 141
Study 25756412 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled volatile anesthetic agents (isoflurane or sevoflurane) (n = 67)
Number of subjects: 141
Study 23815747 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block (20 mL of either 0.375% ropivacaine or 0.3% levobupivacaine)
Number of subjects: 94
Study 23815747 — intervention group
Group type: COMPARATOR
Intervention: Control (epidural morphine 2 mg)
Number of subjects: 94
Study 23815747 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block (local anesthetics)
Number of subjects: 94
Study 20391324 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus knee brace (M4 OA®, Medi) applied for 2-4 hours per day during activity (n = 13)
Number of subjects: 33
Study 20391324 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic knee bandage (Genumedi®, Medi) applied for 2-4 hours per day during activity (n = 10)
Number of subjects: 33
Study 20391324 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated individuals) (n = 10)
Number of subjects: 33
Study 20391324 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus knee brace (M4 OA®, Medi)
Number of subjects: 33
Study 18992248 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 538
Study 18992248 — intervention group
Group type: COMPARATOR
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 538
Study 16895944 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate computed tomography
Number of subjects: 2602
Study 16895944 — intervention group
Group type: COMPARATOR
Intervention: Admission for observation
Number of subjects: 2602
Study 16895944 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate computed tomography and Admission for observation
Number of subjects: 2602
Study 14984497 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) 200 microg/m2
Number of subjects: 110
Study 14984497 — intervention group
Group type: COMPARATOR
Intervention: No GM‐CSF
Number of subjects: 110
Study 11354565 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization
Number of subjects: 267
Study 9507791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 179
Study 9507791 — intervention group
Group type: EXPERIMENTAL
Intervention: NPY
Number of subjects: 179
Study 9507791 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of hypertension
Number of subjects: 179
Study 7999177 — intervention group
Group type: EXPERIMENTAL
Intervention: DEU rotation
Number of subjects: 21
Study 7999177 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 3370986 — intervention group
Group type: EXPERIMENTAL
Intervention: K salt supplementation
Number of subjects: 0
Study 3370986 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium blocker (triamterene)
Number of subjects: 0
Study 30209712 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage (7 sessions over 3 weeks)
Number of subjects: 40
Study 30209712 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hand massage)
Number of subjects: 40
Study 27213725 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to multiple individuals exhibiting within-person variability in facial emotion
Number of subjects: 0
Study 27213725 — intervention group
Group type: COMPARATOR
Intervention: Exposure to multiple individuals exhibiting a single facial emotion
Number of subjects: 0
Study 25686299 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral Block (PVB)
Number of subjects: 40
Study 25686299 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 40
Study 21486110 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 42
Study 21486110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 21573941 — intervention group
Group type: EXPERIMENTAL
Intervention: Red pepper (150 mg of red pepper powder, 4 pills/day for 6 weeks)
Number of subjects: 50
Study 21573941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21573941 — intervention group
Group type: EXPERIMENTAL
Intervention: Red pepper
Number of subjects: 50
Study 18065406 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPIRI + celecoxib (C)
Number of subjects: 85
Study 18065406 — intervention group
Group type: COMPARATOR
Intervention: CAPIRI + placebo (P)
Number of subjects: 85
Study 18065406 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI + celecoxib (C)
Number of subjects: 85
Study 18065406 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI + placebo (P)
Number of subjects: 85
Study 18065406 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPIRI
Number of subjects: 85
Study 18065406 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI
Number of subjects: 85
Study 18065406 — intervention group
Group type: EXPERIMENTAL
Intervention: celecoxib
Number of subjects: 85
Study 18065406 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 85
Study 16501249 — intervention group
Group type: EXPERIMENTAL
Intervention: WRN Cys1367Arg polymorphism
Number of subjects: 1828
Study 16501249 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 MspI 1798G>A (16 bp insertion/duplication)
Number of subjects: 1828
Study 16501249 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint effect of WRN Cys1367Arg and p53 MspI
Number of subjects: 1828
Study 14665655 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein levels (measured at baseline)
Number of subjects: 20525
Study 10893594 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cc of 2% intrarectal lidocaine 10 minutes before the procedure
Number of subjects: 50
Study 10893594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study 8883009 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine supplementation (5,000 mg.day‐1)
Number of subjects: 10
Study 8883009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1547685 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐I‐(7‐37) infusion (1‐5 ng.kg‐1.min‐1 for 30 min)
Number of subjects: 15
Study 1547685 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐I‐(7‐37) infusion concurrent with a standard meal
Number of subjects: 15
Study 1547685 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐I‐(7‐37) infusion
Number of subjects: 15
Study 1547685 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 15
Study 3524234 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal acoustic stimulation test (transabdominal acoustic stimulation with a Model 5C electronic artificial larynx)
Number of subjects: 100
Study 3524234 — intervention group
Group type: COMPARATOR
Intervention: Nonstress test (control group)
Number of subjects: 100
Study 30140006 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS injection
Number of subjects: 22
Study 27032570 — intervention group
Group type: EXPERIMENTAL
Intervention: High monetary incentive
Number of subjects: 0
Study 27032570 — intervention group
Group type: COMPARATOR
Intervention: Low monetary incentive
Number of subjects: 0
Study 27032570 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger primes
Number of subjects: 0
Study 25831646 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration and injection treatment (Triamcinolone acetonide)
Number of subjects: 173
Study 25831646 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision
Number of subjects: 173
Study 25831646 — intervention group
Group type: COMPARATOR
Intervention: Comparison of failure rates
Number of subjects: 173
Study 23355624 — intervention group
Group type: COMPARATOR
Intervention: Top quartile hospitals (high ICU admission)
Number of subjects: 166224
Study 23355624 — intervention group
Group type: EXPERIMENTAL
Intervention: Other hospitals (lower ICU admission)
Number of subjects: 166224
Study 23355624 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall HF in-hospital risk-standardized mortality
Number of subjects: 166224
Study 21176524 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg recombinant CHO hepatitis B vaccine
Number of subjects: 642
Study 21176524 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg recombinant CHO hepatitis B vaccine
Number of subjects: 642
Study 18655742 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous carbon dioxide pressure monitoring (P(tcCO(2))) during daytime spontaneous breathing trials (SBTs)
Number of subjects: 15
Study 18655742 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous carbon dioxide pressure monitoring (P(tcCO(2))) during first nights off the ventilator
Number of subjects: 15
Study 18655742 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous carbon dioxide pressure monitoring (P(tcCO(2))) during bronchoscopy
Number of subjects: 15
Study 18655742 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of P(tcCO(2)) and P(aCO(2))
Number of subjects: 15
Study 18655742 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of P(aCO(2)) and P(ETCO(2))
Number of subjects: 15
Study 20092773 — intervention group
Group type: EXPERIMENTAL
Intervention: No drain (Group A)
Number of subjects: 100
Study 20092773 — intervention group
Group type: COMPARATOR
Intervention: With drain (Group B)
Number of subjects: 100
Study 20092773 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 100
Study 15685823 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (800 mg/m2 days 1 and 8), Epirubicin (90 mg/m2 day 1), Docetaxel (75 mg/m2 day 1) with prophylactic filgrastim (Neupogen)
Number of subjects: 77
Study 12575551 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medication of Songling Xue-maikang Capsule (SXC) with captopril
Number of subjects: 166
Study 12575551 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 166
Study 9456419 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical and subconjunctival anesthesia with lidocaine 4%
Number of subjects: 402
Study 9456419 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar injection of lidocaine 4%
Number of subjects: 402
Study 7943774 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg (M high)
Number of subjects: 52
Study 7943774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 0.1 mg/kg (L high)
Number of subjects: 52
Study 7943774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 3285830 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg torasemide
Number of subjects: 19
Study 3285830 — intervention group
Group type: COMPARATOR
Intervention: 40 mg furosemide
Number of subjects: 19
Study 31076850 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Number of subjects: 63
Study 31076850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 31470366 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal jelly (1000 mg daily for eight weeks)
Number of subjects: 200
Study 31470366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 28068681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (≈14 vol%O2)
Number of subjects: 9
Study 28068681 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia (≈21 vol%O2)
Number of subjects: 9
Study 28068681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia/Hyperoxia (≈14 vol%O2/≈30 vol%O2, 5‐min intervals)
Number of subjects: 9
Study 25611825 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist ratings of resistance
Number of subjects: 40
Study 25611825 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer ratings of resistance
Number of subjects: 40
Study 23887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 5515
Study 21914281 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu (SF) injection administered by peripheral intravenous infusion at initially 0.2 ml/kg and then 0.8 ml×kg(‐1)×h(‐1) until the end of operations
Number of subjects: 24
Study 21914281 — intervention group
Group type: COMPARATOR
Intervention: Normal saline administered similarly to Group S
Number of subjects: 24
Study 21914281 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu (SF) injection
Number of subjects: 24
Study 19995250 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction mammaplasty (surgery)
Number of subjects: 82
Study 19995250 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (control)
Number of subjects: 82
Study 17468908 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Stat Dry bandage as an adjunct to manual compression
Number of subjects: 376
Study 17468908 — intervention group
Group type: COMPARATOR
Intervention: Manual compression alone
Number of subjects: 376
Study 15269068 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse led clinic (NLC)
Number of subjects: 102
Study 15269068 — intervention group
Group type: COMPARATOR
Intervention: Consultant led paediatric gastroenterology clinic (PGC)
Number of subjects: 102
Study 11316648 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐O2 gas mixture (79% He, 21% O2)
Number of subjects: 10
Study 11316648 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 10
Study 9228270 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler (p‐TCCS)
Number of subjects: 12
Study 9228270 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler frequency imaging mode (f‐TCCS)
Number of subjects: 12
Study 8076711 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (30 g/day for 3 days prior to each course of chemotherapy)
Number of subjects: 0
Study 8076711 — intervention group
Group type: COMPARATOR
Intervention: CHOP chemotherapy only
Number of subjects: 0
Study 8076711 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation
Number of subjects: 0
Study 3111144 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomy
Number of subjects: 20
Study 3111144 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-splenectomised CLL patients)
Number of subjects: 20
Study 29545253 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of bone marrow-derived mononuclear cells
Number of subjects: 20
Study 29545253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stem cell infusion)
Number of subjects: 20
Study 27276739 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomaltulose (ISO) breakfast
Number of subjects: 0
Study 27276739 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (SUC) breakfast
Number of subjects: 0
Study 23324726 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week aerobic exercise intervention
Number of subjects: 123
Study 23324726 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study 22898557 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA‐TT (MenAfriVac™)
Number of subjects: 340
Study 22898557 — intervention group
Group type: COMPARATOR
Intervention: PsACWY (Mencevax ACWY(®))
Number of subjects: 340
Study 20351589 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week exercise intervention
Number of subjects: 0
Study 20351589 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 0
Study 20351589 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week exercise intervention (l allele carriers)
Number of subjects: 0
Study 20351589 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week exercise intervention (ss individuals)
Number of subjects: 0
Study 18657684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast ForWord (FFW, experimental group)
Number of subjects: 65
Study 18657684 — intervention group
Group type: COMPARATOR
Intervention: SuccessMaker (SM, active control group)
Number of subjects: 65
Study 18657684 — intervention group
Group type: EXPERIMENTAL
Intervention: FFW followed by SM
Number of subjects: 65
Study 18657684 — intervention group
Group type: EXPERIMENTAL
Intervention: SM followed by FFW
Number of subjects: 65
Study 18657684 — intervention group
Group type: COMPARATOR
Intervention: No intervention beyond the regular class curriculum (developmental control group)
Number of subjects: 65
Study 15935432 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol infusion
Number of subjects: 26
Study 15935432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 12500933 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy Management Care Plan (PMCP)
Number of subjects: 65
Study 12500933 — intervention group
Group type: COMPARATOR
Intervention: Exercise instruction booklet (Control Group)
Number of subjects: 65
Study 9457834 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Gy/2 fractions (group A)
Number of subjects: 172